Angiodynamics Stock Buy Hold or Sell Recommendation
| ANGO Stock | USD 6.74 0.02 0.30% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding AngioDynamics is 'Strong Sell'. The recommendation algorithm takes into account all of AngioDynamics' available fundamental, technical, and predictive indicators you will find on this site.
Check out AngioDynamics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide. In addition, we conduct extensive research on individual companies such as AngioDynamics and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards AngioDynamics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
AngioDynamics |
Execute AngioDynamics Buy or Sell Advice
The AngioDynamics recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on AngioDynamics. Macroaxis does not own or have any residual interests in AngioDynamics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute AngioDynamics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
AngioDynamics Trading Alerts and Improvement Suggestions
| AngioDynamics generated a negative expected return over the last 90 days | |
| AngioDynamics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 303.91 M. Net Loss for the year was (184.35 M) with profit before overhead, payroll, taxes, and interest of 174.25 M. | |
| AngioDynamics currently holds about 24.56 M in cash with (28.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31. | |
| Over 81.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from zacks.com: GE HealthCare and DeepHealth Collaborate to Advance AI in Imaging |
AngioDynamics Returns Distribution Density
The distribution of AngioDynamics' historical returns is an attempt to chart the uncertainty of AngioDynamics' future price movements. The chart of the probability distribution of AngioDynamics daily returns describes the distribution of returns around its average expected value. We use AngioDynamics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of AngioDynamics returns is essential to provide solid investment advice for AngioDynamics.
| Mean Return | -0.12 | Value At Risk | -4.03 | Potential Upside | 3.71 | Standard Deviation | 3.29 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of AngioDynamics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
AngioDynamics Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as AngioDynamics, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading AngioDynamics back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
| Shares | Armistice Capital, Llc | 2024-06-30 | 836 K | State Street Corp | 2024-06-30 | 789.2 K | Kent Lake Capital Llc | 2024-06-30 | 750 K | Two Sigma Advisers, Llc | 2024-06-30 | 568.7 K | Jacobs Levy Equity Management, Inc. | 2024-06-30 | 509.3 K | Two Sigma Investments Llc | 2024-06-30 | 485.4 K | Paradigm Capital Management, Inc. | 2024-06-30 | 478 K | Jpmorgan Chase & Co | 2024-06-30 | 429.9 K | Assenagon Asset Management Sa | 2024-09-30 | 425.1 K | Blackrock Inc | 2024-06-30 | 4.6 M | Vanguard Group Inc | 2024-09-30 | 2.3 M |
AngioDynamics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (18.8M) | 11.5M | (2.8M) | (8.2M) | (9.4M) | (8.9M) | |
| Change In Cash | (173.2M) | (6.3M) | (19.3M) | 15.8M | 31.4M | 33.0M | |
| Free Cash Flow | (22.1M) | 10.4M | (11.5M) | (4.3M) | (33.9M) | (32.2M) | |
| Depreciation | 23.8M | 25.9M | 29.3M | 30.9M | 27.7M | 18.7M | |
| Other Non Cash Items | 150.0M | 16.8M | 4.1M | 19.8M | 111.5M | 117.1M | |
| Capital Expenditures | 7.6M | 13.7M | 4.3M | 4.4M | 5.8M | 7.4M | |
| Net Income | (165.8M) | (31.5M) | (26.5M) | (52.4M) | (184.3M) | (175.1M) | |
| End Period Cash Flow | 54.4M | 48.2M | 28.8M | 44.6M | 76.1M | 47.3M | |
| Change To Netincome | 156.5M | 23.0M | 11.1M | 28.5M | 32.8M | 34.4M | |
| Investments | (63.3M) | (8.5M) | (11.4M) | (9.7M) | 123.7M | 129.9M | |
| Change Receivables | 11.9M | (4.2M) | (17.2M) | (1.3M) | (1.2M) | (1.2M) | |
| Net Borrowings | (93.3M) | (20M) | 5M | 24.2M | 21.8M | 22.9M |
AngioDynamics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to AngioDynamics or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that AngioDynamics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a AngioDynamics stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.07 | |
β | Beta against Dow Jones | -0.64 | |
σ | Overall volatility | 3.35 | |
Ir | Information ratio | -0.07 |
AngioDynamics Volatility Alert
AngioDynamics exhibits very low volatility with skewness of -1.35 and kurtosis of 10.7. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure AngioDynamics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact AngioDynamics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.AngioDynamics Fundamentals Vs Peers
Comparing AngioDynamics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze AngioDynamics' direct or indirect competition across all of the common fundamentals between AngioDynamics and the related equities. This way, we can detect undervalued stocks with similar characteristics as AngioDynamics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of AngioDynamics' fundamental indicators could also be used in its relative valuation, which is a method of valuing AngioDynamics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare AngioDynamics to competition |
| Fundamentals | AngioDynamics | Peer Average |
| Return On Equity | -0.78 | -0.31 |
| Return On Asset | -0.0612 | -0.14 |
| Profit Margin | (0.83) % | (1.27) % |
| Operating Margin | (0.13) % | (5.51) % |
| Current Valuation | 223.67 M | 16.62 B |
| Shares Outstanding | 40.63 M | 571.82 M |
| Shares Owned By Insiders | 5.47 % | 10.09 % |
| Shares Owned By Institutions | 81.40 % | 39.21 % |
| Number Of Shares Shorted | 1.23 M | 4.71 M |
| Price To Earning | 7.90 X | 28.72 X |
| Price To Book | 1.39 X | 9.51 X |
| Price To Sales | 0.96 X | 11.42 X |
| Revenue | 303.91 M | 9.43 B |
| Gross Profit | 174.25 M | 27.38 B |
| EBITDA | (14.29 M) | 3.9 B |
| Net Income | (184.35 M) | 570.98 M |
| Cash And Equivalents | 24.56 M | 2.7 B |
| Cash Per Share | 0.31 X | 5.01 X |
| Total Debt | 5.91 M | 5.32 B |
| Debt To Equity | 0.14 % | 48.70 % |
| Current Ratio | 2.28 X | 2.16 X |
| Book Value Per Share | 4.79 X | 1.93 K |
| Cash Flow From Operations | (28.16 M) | 971.22 M |
| Short Ratio | 1.67 X | 4.00 X |
| Earnings Per Share | (6.05) X | 3.12 X |
| Price To Earnings To Growth | 1.87 X | 4.89 X |
| Target Price | 13.0 | |
| Number Of Employees | 748 | 18.84 K |
| Beta | 0.67 | -0.15 |
| Market Capitalization | 282.41 M | 19.03 B |
| Total Asset | 317.67 M | 29.47 B |
| Retained Earnings | (395.2 M) | 9.33 B |
| Working Capital | 102.1 M | 1.48 B |
Note: Acquisition by Chad Campbell of 8610 shares of AngioDynamics subject to Rule 16b-3 [view details]
AngioDynamics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as AngioDynamics . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About AngioDynamics Buy or Sell Advice
When is the right time to buy or sell AngioDynamics? Buying financial instruments such as AngioDynamics Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having AngioDynamics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Shipbuilding Railroad Equipment Thematic Idea Now
Shipbuilding Railroad Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipbuilding Railroad Equipment theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipbuilding Railroad Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Check out AngioDynamics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.05) | Revenue Per Share 7.249 | Quarterly Revenue Growth (0.14) | Return On Assets (0.06) | Return On Equity (0.78) |
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.